Oleoylethanolamide ameliorates motor dysfunction through PPARα-mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke

Phytother Res. 2023 Nov;37(11):5341-5353. doi: 10.1002/ptr.7970. Epub 2023 Sep 12.

Abstract

Background and aim: Our previous study has revealed that OEA promotes motor function recovery in the chronic stage of ischemic stroke. However, the neuroprotective mechanism of OEA on motor function recovery after stroke still is unexplored. Therefore, the aim of this study was to explore the effects of OEA treatment on angiogenesis, neurogenesis, and white matter repair in the peri-infarct region after cerebral ischemia.

Experimental procedure: The adult male rats were subjected to 2 h of middle cerebral artery occlusion. The rats were treated with 10 and 30 mg/kg OEA or vehicle daily starting from day 2 after ischemia induction until they were sacrificed.

Key results and conclusions: The results revealed that OEA increased cortical angiogenesis, neural progenitor cells (NPCs) proliferation, migration, and differentiation. OEA treatment enhanced the survival of newborn neurons and oligodendrogenesis, which eventually repaired the cortical neuronal injury and improved motor function after ischemic stroke. Meanwhile, OEA treatment promoted the differentiation of oligodendrocyte progenitor cells (OPCs) and oligodendrogenesis by activating the PPARα signaling pathway. Our results showed that OEA restores motor function by facilitating cortical angiogenesis, neurogenesis, and white matter repair in rats after ischemic stroke. Therefore, we demonstrate that OEA facilitates functional recovery after ischemic stroke and propose the hypothesis that the long-term application of OEA mitigates the disability after stroke.

Keywords: Oleoylethanolamide; angiogenesis; focal cerebral ischemia; neurogenesis; white matter repair.

MeSH terms

  • Animals
  • Brain Ischemia* / drug therapy
  • Cell Differentiation
  • Ischemic Stroke*
  • Male
  • Neurogenesis
  • Oligodendroglia / metabolism
  • PPAR alpha / metabolism
  • Rats
  • Stroke* / drug therapy
  • White Matter* / metabolism

Substances

  • oleoylethanolamide
  • PPAR alpha
  • oleoyl ethanolamine